Marco Trucco 2022. Two Cases of New Daily Persistent Headache Successfully Treated with Onabotulinum Toxin Type A (BoNT-A). Current Innovations in Medicine and Medical Science Vol. 7. (Nov. 2022), 169–178. DOI:https://doi.org/10.9734/bpi/cimms/v7/4654A.